Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Size Valuation Forecast: What Will the Market Be Worth by 2025?_x000D_
In recent times, the market for polymerase chain reactions (PCR) devices, reagents, and uses has witnessed strong growth. The forecast predicts a growth from $6.19 billion in 2024 to $6.51 billion in 2025, signifying a compound annual growth rate (CAGR) of 5.0%. The historic growth has been driven by factors such as growing prevalence of infectious diseases, escalated demand for clinical diagnostic solutions, burgeoning need for personalized medicine, and an upward trend in the adoption of PCR in research and development._x000D_
_x000D_
Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Size Forecast: What's the Projected Valuation by 2029?_x000D_
The market encompassing PCR (polymerase chain reactions) devices, reagents, and uses is projected to witness robust growth in the ensuing years. By 2029, the market is estimated to have expanded to $9.01 billion, marking a compound annual growth rate (CAGR) of 8.5%. The notable growth during the forecast period is attributed to factors such as monitoring of COVID-19 and other infectious diseases, cancer diagnostics, and liquid biopsies, along with applications in agriculture and the environment. Other contributing elements include advancements in genomic research and the expansion of pharmacogenomics. Key trends to watch during this period include the development of digital and multiplex PCR, integration with next-generation sequencing (NGS), miniaturization, the rise of portable devices, the adoption of artificial intelligence and data analytics, and the integration of automation and robotics._x000D_
_x000D_
View the full report here: _x000D_
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report_x000D_
_x000D_
What Are the Drivers Transforming the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?_x000D_
Global increases in infectious diseases are propelling the market for polymerase chain reaction devices, reagents, and their uses. These devices are utilized in clinical labs to identify the existence of infectious diseases. The World Health Organization released a report indicating approximately 17 million people perish annually as a result of infectious diseases, and another 30 new types have surfaced in the past two decades. Moreover, in August 2024, the UK Health Security Agency - a governing body in the UK, disclosed a spike in the number of measles cases in England with 368 reported cases in 2023. This showed a near 7-fold increase compared to the previous year (when 53 cases were recorded). Such events are causing a surge in the demand for clinical diagnostic services, hence driving growth in the polymerase chain reaction devices, reagents, and uses market._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=2485&type=smp_x000D_
_x000D_
What Long-Term Trends Will Define the Future of the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market? _x000D_
The unveiling of new options contributes significantly to the slowdown in the polymerase chain reaction devices and reagents market growth. Polymerase chain reaction methodology faces competition from the likes of Next Generation Sequencing and Sanger Sequencing in the DNA sequencing domain. These alternatives not only offer equivalent benefits to PCR devices and reagents but, in certain cases, surpass them, thereby intensifying the market competition and hampering the PCR devices and reagents' growth. As illustration, a specific study researched 138 FFPE non-small lung cancer samples, utilizing assays created via Sanger, Next Generation Sequencing, and polymerase chain reaction methods. The study concluded that NGS and QPCR assays demonstrated similar analytical sensitivity, simplicity, and consistency. Furthermore, NGS assays displayed superior information clarity regarding allele sequence, mutation frequency, and non-hotspot mutation detection compared to qPCR. Therefore, the advent of these alternative methods is likely to limit the respective market's expansion throughout the projection period._x000D_
_x000D_
Which Segments in the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Offer the Most Profit Potential?_x000D_
The polymerase chain reactions (PCR) devices, reagents and uses market covered in this report is segmented - _x000D_
_x000D_
1) By Product: Instruments, Reagents, Consumables _x000D_
2) By Instruments: Standard PCR, RT-PCR, Digital PCR _x000D_
3) By End User: Pharmaceutical and biotechnology industries, Clinical Diagnostics labs and hospitals, Academics and research organization _x000D_
_x000D_
Subsegments:_x000D_
1) By Instruments: Thermal Cyclers, Real-Time PCR Systems, Digital PCR Systems_x000D_
2) By Reagents: Master Mixes, Primers And Probes, Enzymes, Nucleotides_x000D_
3) By Consumables: PCR Tubes, PCR Plates, Seals And Films, Pipette Tips_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=2485&type=smp_x000D_
_x000D_
Which Firms Dominate the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market by Market Share and Revenue in 2025?_x000D_
Major companies operating in the polymerase chain reactions (PCR) devices, reagents and uses market include Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc. _x000D_
_x000D_
Which Regions Offer the Highest Growth Potential in the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?_x000D_
The countries covered in the polymerase chain reactions (PCR) devices, reagents and uses market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada._x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2485_x000D_
_x000D_
"This Report Supports:_x000D_
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.